Skip to content

Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)

Open Randomized Study of Patients With Chronic Heart Failure and Cheyne Stokes Respiration Pattern, Treated With ASV. (Adaptive Servo Ventilator).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00563693
Acronym
3C
Enrollment
40
Registered
2007-11-26
Start date
2007-09-30
Completion date
2011-01-31
Last updated
2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Cheyne Stokes Respiration

Keywords

heart failure, cheyne stokes respiration, adaptive servo ventilator

Brief summary

An investigation where patients with chronic heart failure and cheyne stokes respiration, treated with adapitve servo ventilator, will improve their cardiac function and quality of life.

Detailed description

Chronic heart failure (HF) is one of the most important public health problems in cardiovascular medicine. Several patients with chronic heart failure also has Cheyne Stokes respiration pattern. Earlier studies have shown that this respiration pattern improves with Adaptive servo ventilator. We wish to investigate wether this leads to improved cardiac function.

Interventions

DEVICEASV

Adaptive servo ventilator

OTHERwithout Autoset CS2

without Autoset CS2

Sponsors

ResMed
CollaboratorINDUSTRY
University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Ejection fraction \<40% * NYHA class III-IV * Optimized therapy with drugs * Cheyne stokes respiration pattern \> 25% while sleeping * Age \< 85 years * clinical stability the last month before inclusion.

Exclusion criteria

* CABG less then 6 months ago * PCI treatment less then 3 months ago * Unstable angina pectoris * Acute coronary syndrome less then 3 months ago * Stroke less then 6 weeks ago * Thoracal myopathy * Advanced COPD

Design outcomes

Primary

MeasureTime frame
Ejection fraction (measured with echocardiography) and inflammatory markers3 months

Secondary

MeasureTime frame
6 minutes walking test Quality of life Changes in cathecolamines Altered frequency of arrythmias3 months

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026